New research advocates genetic screening in early onset atrial fibrillation

FHS
March 28, 2024
11:53 pm

Although the vast majority of clinicians do not view atrial fibrillation (AF) as a genetic disorder, a White Paper in the Canadian Journal of Cardiology, published by Elsevier, analyzes the current understanding of genetics and the role of genetic testing in AF and concludes there is an increasing appreciation that genetic culprits for potentially life-threatening ventricular cardiomyopathies and channelopathies may initially present with AF.

Still In a Bear Market

You’re reading a copy of this week’s edition of the New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. The newsletter

October 8, 2023

Opinion | Your Patient Has Been Dealt a Hand With Four ACEs. What Now?

DuPree is a breast cancer surgeon. In most card games, four aces are desirable. Conversely, an “ACE” — adverse childhood experiences — score of 4

August 31, 2024

Anti-TIGIT Drug Fails to Lift Response Rates in Cervical Cancer Trial

Combining the novel anti-TIGIT monoclonal antibody tiragolumab with atezolizumab (Tecentriq) to treat PD-L1-positive recurrent cervical cancer didn’t improve overall response rate in the phase II

November 22, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.